COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
3.750
+0.190 (5.34%)
Nov 4, 2024, 4:00 PM EST - Market closed
COSCIENS Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 13 | 9 | 15 | 44 | 27 | 18 | |
| Market Cap Growth | 10.86% | -38.75% | -64.65% | 64.32% | 44.53% | -62.43% | |
| Enterprise Value | -12 | -30 | -39 | -24 | 4 | 8 | |
| Last Close Price | 3.56 | 7.44 | 12.72 | 35.53 | 42.55 | 91.00 | |
| Debt / Equity Ratio | 0.06 | 0.02 | 0.01 | 0.00 | 0.01 | -0.37 | |
| Debt / FCF Ratio | -0.08 | -0.02 | -0.01 | -0.02 | -0.04 | -0.08 | |
| Asset Turnover | 0.10 | 0.10 | 0.08 | 0.09 | 0.13 | 0.02 | |
| Inventory Turnover | 0.57 | 1.51 | 1.04 | 1.91 | 3.31 | 0.46 | |
| Quick Ratio | 2.95 | 7.57 | 7.49 | 8.88 | 5.60 | 1.50 | |
| Current Ratio | 3.36 | 8.01 | 7.88 | 9.12 | 5.82 | 1.93 | |
| Return on Equity (ROE) | -65.92% | -61.34% | -51.21% | -25.28% | -95.24% | - | |
| Return on Assets (ROA) | -23.34% | -24.19% | -14.12% | -9.26% | -13.00% | -26.99% | |
| Return on Capital (ROIC) | -39.37% | -41.36% | -21.57% | -16.29% | -62.56% | -1114.90% | |
| Buyback Yield / Dilution | -7.69% | - | -5.63% | -179.74% | -134.83% | -2.70% | |
| Total Shareholder Return | -7.69% | - | -5.63% | -179.74% | -134.83% | -2.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.